Evaluation of the Effect of Adenoid Hypertrophy on the Masseter Muscle in Children: A Comparative Ultrasonographic Study

NCT ID: NCT07094581

Last Updated: 2025-12-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

72 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-07-20

Study Completion Date

2026-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to evaluate the effect of adenoid hypertrophy on the masseter muscle in children aged 3 to 8 years. The primary objectives are:

* To assess whether adenoid hypertrophy affects the thickness or structure of the masseter muscle.
* To determine whether there is a measurable difference in masseter muscle characteristics between children with and without adenoid hypertrophy.

Researchers will compare children diagnosed with adenoid hypertrophy and scheduled for adenoidectomy to healthy controls without adenoid hypertrophy.

Each participant will:

* Undergo ultrasonographic examination of the masseter muscle using a 9L linear probe (6-15 MHz), and
* Have their occlusal relationship, dental findings, age, sex, and adenoid hypertrophy grade recorded.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Hypotheses

H0 (Null Hypothesis): There is no difference in masseter muscle thickness or the visibility of internal echogenic bands between children with adenoid hypertrophy and healthy controls.

H1 (Alternative Hypothesis): There is a difference in masseter muscle thickness or the visibility of internal echogenic bands between children with adenoid hypertrophy and healthy controls.

Sample Size Calculation No prior studies were identified comparing masseter muscle thickness between children with adenoid hypertrophy and healthy controls. The sample size was calculated using G\*Power software. Assuming a medium effect size (0.6), an alpha level of 0.05, and a power of 0.80, the required total sample size was determined to be 72 participants.

Ultrasound Evaluation of the Masseter Muscle

Masseter muscle thickness and the visibility of internal echogenic bands will be assessed bilaterally at rest and during maximum clenching (intercuspal position). Evaluations will be performed with participants in the supine position. The ultrasound probe will be placed:

* Transversely: Parallel to the inferior mandibular border along a line connecting the oral commissure and the tragus.
* Longitudinally: Perpendicular to the mandibular body.

Thickness measurements (mm) will be taken from the thickest part of the muscle in both positions. Visibility of internal echogenic bands will be classified as follows:

* Type 1: Clear visibility of thin transverse bands.
* Type 2: Thickened bands with reduced echogenicity.
* Type 3: Disappearance or reduction in the number of bands.

Evaluations will be performed by the investigator (SY) at the Department of Oral and Maxillofacial Radiology, Faculty of Dentistry, Aydın Adnan Menderes University.

Clinical Examination The principal investigator (BMA) will record each participant's age, sex, adenoid hypertrophy grade, occlusion type, molar relationship classification, overjet, overbite, number of carious, missing, and filled teeth, and the presence of mouth breathing and bruxism.

Statistical and Analytical Methods Data will be analyzed using SPSS version 19.0 (IBM Corp.). The Kolmogorov-Smirnov test will be used to assess normality of distribution. Categorical variables will be expressed as frequencies and percentages; continuous variables will be presented as means and standard deviations. The independent samples t-test will be used to compare measurement data between groups. The chi-square test will be used to evaluate associations between categorical variables and adenoid hypertrophy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Adenoid Hypertrophy Masseter Muscle Malocclusion

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Adenoid Hypertrophy Ultrasonography Masseter Muscle

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Adenoid Hypertrophy Group

Children aged 3-8 years diagnosed with adenoid hypertrophy.

USG

Intervention Type DIAGNOSTIC_TEST

Masseter Muscle Thickness and Internal Echogenic Bands Assessed by Ultrasonography

Healthy Control Group

Healthy children aged 3-8 years without adenoid hypertrophy.

USG

Intervention Type DIAGNOSTIC_TEST

Masseter Muscle Thickness and Internal Echogenic Bands Assessed by Ultrasonography

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

USG

Masseter Muscle Thickness and Internal Echogenic Bands Assessed by Ultrasonography

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children aged between 3 and 8 years
* Children diagnosed with adenoid hypertrophy
* Children without any systemic disease

Exclusion Criteria

* Children with a history of surgery for adenoid hypertrophy
* Children who are uncooperative during clinical examination
* Children with syndromes involving the maxillofacial region
* Children with multiple missing teeth
Minimum Eligible Age

3 Years

Maximum Eligible Age

8 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Melis AKYILDIZ

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Melis AKYILDIZ

Assistant Professor

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Melis Akyıldız, phd

Role: PRINCIPAL_INVESTIGATOR

Aydin Adnan Menderes University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Aydın Adnan Menderes University

Aydin, Efeler, Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Melis Akyıldız, phd

Role: CONTACT

Phone: +905387970703

Email: [email protected]

Esra Dişcioğlu Candemir, dds

Role: CONTACT

Phone: +905073341496

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Melis Akyıldız, phd

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Ariji Y, Sakuma S, Izumi M, Sasaki J, Kurita K, Ogi N, Nojiri M, Nakagawa M, Takenaka M, Katsuse S, Ariji E. Ultrasonographic features of the masseter muscle in female patients with temporomandibular disorder associated with myofascial pain. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 Sep;98(3):337-41. doi: 10.1016/j.tripleo.2004.06.068.

Reference Type BACKGROUND
PMID: 15356473 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023/37

Identifier Type: -

Identifier Source: org_study_id